Question 1

What is Lateral Pharma?

Accepted Answer

Lateral Pharma is a Entity.

Question 2

How often does Lateral Pharma appear in global news?

Accepted Answer

Tracked across 1 news events drawn from 10 articles.

Question 3

When was Lateral Pharma first tracked by Ergen?

Accepted Answer

First tracked on Jun 11, 2026.

Question 4

When was Lateral Pharma last mentioned in news?

Accepted Answer

Last active on Jun 12, 2026.

Question 5

What is Lateral Pharma's current news sentiment?

Accepted Answer

Aggregate sentiment score: 75 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is Lateral Pharma in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 1 events.

Question 7

What is the most recent event involving Lateral Pharma?

Accepted Answer

Lateral Pharma identifies neuropathic pain target (Jun 11, 2026, 10 articles).

Question 8

How did the "Lateral Pharma identifies neuropathic pain target" event impact Lateral Pharma?

Accepted Answer

Lateral Pharma announced the publication of peer-reviewed research identifying LanCL1 as a novel therapeutic target for neuropathic pain, responsive to its SCP drugs. This validates their Stressed Cell Protectant platform and supports continued development of SCPs, potentially increasing its valuation and future market position.

Question 9

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.